Actualización Medchannel Ginecología: Abordaje terapéutico de obesidad

Por el Dr. Mario Ivan Urbina Sánchez. Especialista en Medicina Interna y Obesidad. Cédula Médico General 3831834. Cédula de Especialidad 5643466

Referencias:

1. NIH Obes Res 1998: 6(Suppl) 2. 51S-209S; Schelbert. Prim Care 2009;36:271-85; WHO. Factsheet 311 2012. who.int/mediacentre/factssheets/fs311/en. Guh et al. BMC Public Health 2009 ;9 :88.
2. Factsheet 311 2014. www.who.int
3. Pasarica, Magdalena, et al. “Reduced Adipose Tissue Oxygenation in Human Obesity Evidence for Rarefaction, Macrophage Chermotaxis and Inflammation without and Angiogenic Response” National Center of Biotechnology Information (NCBI), Pub Med, 2009.
4. Badman, Flier. Science 2005; 307:1909-14; 2. US Department of Health and Human Services, 1998. NIH Publication No. 98-4083.
5. AMA American Medical Association, NAFD non alcoholic fatty liver disease.
6. Cefalu et al Diabetes Care 2015 ;38 :1567-82 ; Lean et al, Lancet 2018 :391 :541-51
7. Am Sharma and RF Kushner International Journey of Obesity (2009) 33, 289-295
8. CMAJ Aug 2020, 192 (31) E875-E891
9. Sacks et al N Engl J Med 2009 ; 360(9) :859-873
10. Ajala O, English P. Pinkney J. Am J Clin Nutr. 2013 Mar; 97(3):505-16.
11. Wycherley TP, et al. Am J Clin Nutr. 2012 Dec; 96(6):1281-98.
12. Hu T. et al. Am J Epidemiol. 2012 Oct 1:176 Suppl 7:S44-54.
13. Tanaka et al. J Phys Fitness Sport Med 2012; 1:457-465.
14. Weintraub et al. Arch Intern med 1984; 144:1143-8;2. Munro et al. Br Med J 1968 ;1 :352-4.
15. Baseline : weight, 110.5 ; kg ; BMI,37 kg/m2. Xendos, Xenical in the prevention of Diabetes in Obese Subjects Targerson et al. Diabetes Care 2004;27:155-61.
16. GABA, gamma.aminobutyric acid; GLP-1R, glucagon-like peptide-1 receptor; NPY, neuropeptide Y; POMC, pro-opiomelanocortin. Secher et al J Clin Invest 2014; 124: 4473-88.
17. Blundell J et al. Diabetes Obes Metab 2017; 19:1242-1251
18. Journal of Obesity & Metabolic Syndrome 2019;28:158-166.
19. Saint-Maurice PF. Et al JAMA 2020,323(12)1151-1160.

Material desarrollado con fines de educación médica continua.

Material exclusivo para profesionales de la salud.

La información aquí presentada es opinión del ponente.

Código interno de aprobación: MX21SX00158